Mani, Inc. (7730) AI Stock Analysis

• Market Cap: ¥153.49B
• Dividend Yield: 2.73%
• Average Volume (3M): 283.94K
• Price to Earnings (P/E): 18.7
• Beta (1Y): 0.94
• Revenue Growth: 5.10%
• EPS Growth: -26.13%
• Country: JP
• Employees: 4,154
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 20.33
• Shares Outstanding: 107,003,280
• 10 Day Avg. Volume: 284,170
• 30 Day Avg. Volume: 283,943
• PEG Ratio: -1.02
• Price to Book (P/B): 2.31
• Price to Sales (P/S): 4.12
• P/FCF Ratio: 201.91
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 71.28
• Revenue Forecast (FY): ¥33.30B

• Rating: 71 Outperform
• Price Target: ¥1,774.00 ▲(18.23% Upside)
• Action: Upgraded Date: 01/16/26
• Date: Action: Upgraded 01/16/26

The score is primarily driven by strong profitability and an exceptionally conservative balance sheet, offset by weak recent free-cash-flow conversion and some net-margin softening. Technicals are positive but look overextended, and valuation is relatively high given the current earnings and cash-flow momentum.

Positive Factors

High gross and operating margins

Sustained high gross margin (~64%) and strong EBIT margin (~27%) indicate durable product-level economics and pricing power in medical consumables. This supports long-term reinvestment in R&D, stable operating cash generation, and resilience to input-cost swings over months.

Negative Factors

Highly volatile and compressed free cash flow

Sharp swings and recent compression in free cash flow reduce the company's ability to fund dividends, buybacks, or opportunistic M&A without tapping equity or reserves. Over the medium term, inconsistent FCF undermines capital-allocation flexibility and investor confidence in cash generation.

Mani, Inc. Business Overview & Revenue Model

Company Description

Mani, Inc. (7730) is a Japanese company specializing in the manufacturing and sale of precision instruments and medical devices. The company is primarily involved in the dental and surgical instrument sectors, providing high-quality products used ...

Read more

Mani, Inc. (7730) is a Japanese company specializing in the manufacturing and sale of precision instruments and medical devices. The company is primarily involved in the dental and surgical instrument sectors, providing high-quality products used ...

How the Company Makes Money

Mani, Inc. generates revenue through the sale of its precision instruments and medical devices to healthcare providers, dental practitioners, and hospitals. The company's revenue streams are primarily driven by its extensive product portfolio, whi...

Read more

Mani, Inc. generates revenue through the sale of its precision instruments and medical devices to healthcare providers, dental practitioners, and hospitals. The company's revenue streams are primarily driven by its extensive product portfolio, whi...

Mani, Inc. Financial Statement Overview

Breakdown	Aug 2025	Aug 2024	Aug 2023	Aug 2022	Aug 2021
Income Statement
Total Revenue	29.97B	28.51B	24.49B	20.42B	17.19B
Gross Profit	19.32B	17.90B	15.42B	12.57B	11.01B
EBITDA	9.56B	10.70B	9.94B	9.17B	7.55B
Net Income	4.64B	6.29B	5.95B	5.29B	4.29B
Balance Sheet
Total Assets	58.19B	57.33B	55.11B	50.18B	42.90B
Cash, Cash Equivalents and Short-Term Investments	18.73B	21.66B	25.43B	22.73B	18.89B
Total Debt	76.00M	83.00M	58.00M	117.00M	128.00M
Total Liabilities	4.63B	5.00B	5.28B	4.76B	3.69B
Stockholders Equity	53.56B	52.33B	49.83B	45.41B	39.20B
Cash Flow
Free Cash Flow	612.00M	397.00M	4.52B	4.76B	2.62B
Operating Cash Flow	7.03B	7.82B	8.03B	6.57B	6.41B
Investing Cash Flow	-7.17B	-6.65B	-4.02B	-2.19B	-3.47B
Financing Cash Flow	-3.90B	-3.70B	-3.25B	-2.44B	-2.23B

Mani, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1500.50
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7730, the sentiment is Positive. The current price of 1500.5 is below the 20-day moving average (MA) of 1535.20, below the 50-day MA of 1560.84, and above the 200-day MA of 1401.18, indicating a neutral trend. The MACD of -1.59 indicates Negative momentum. The RSI at 51.09 is Neutral, neither overbought nor oversold. The STOCH value of 48.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7730.

Mani, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7730	71 Outperform	¥153.49B	18.72	―	2.73%	5.10%	-26.13%
7979	69 Neutral	¥62.62B	19.92	―	2.83%	3.69%	1.86%
7747	68 Neutral	¥933.94B	24.33	11.64%	0.82%	13.53%	-7.39%
7716	63 Neutral	¥241.17B	-69.02	-2.06%	2.66%	5.43%	-20.67%
8086	62 Neutral	¥269.19B	5.59	4.38%	2.03%	6.04%	733.13%
7733	59 Neutral	¥1.69T	38.56	11.34%	1.01%	0.42%	34.76%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%